BridgeMD
New treatment option for Gastrointestinal Neoplasm Malignant
Official title Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
ClinicalTrials.gov ID: NCT06002425
What this study is testing
- What it's testing
- This study will evaluate the utility of ChatGPT in recommending treatment plans for patients with gastrointestinal cancers, using both retrospective and prospective data.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years, both male and female.
- Pathologically confirmed diagnosis of gastrointestinal cancer (gastric cancer or colorectal Cancer).
- Detailed medical records available prior to treatment (including chief complaint, history of present illness, radiological examinations, pathological...
- Participants will receive complete treatment in the participating hospitals.
You likely can't join if
- Participants with cancers other than gastrointestinal cancers.
- Participants who receive treatment in multiple hospitals.
The study team makes the final eligibility decision.
Where it's taking place
- Duarte, California, United States
- Jiangmen, Guangdong, China
- Zhuhai, Guangdong, China
- Hohhot, Inner Mongolia, China
- Magdeburg, Saxony-Anhalt, Germany
- Milan, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Duarte, California, United States; Jiangmen, Guangdong, China; Zhuhai, Guangdong, China; Hohhot, Inner Mongolia, China; Magdeburg, Saxony-Anhalt, Germany; Milan, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.